年間 6 号発行
ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502
Indexed in
Cellular Actions and Signaling by Endostatin
要約
The malignant transformation of a normal cell into a cancer cell requires no vasculature. Growth of solid tumors, however, requires angiogenesis to provide oxygen and nutrients to support cell proliferation. The switch from an avascular to a vascular phenotype is typically associated with acceleration of tumor growth. Antiangiogenic therapy, starving a tumor of its blood supply, is an attractive addition to the anticancer armamentarium. Animal tests of antiangiogenic therapy have shown remarkable potential. Initial human trials have proven antiangiogenic therapy to be remarkably nontoxic. Numerous antiangiogenic agents have been isolated as proteolytic fragments of endogenous polypeptides of the extracellular matrix. Endostatin was the first such antiangiogenic protein described and its potent antitumor effects in mice have generated wide interest. This review summarizes recent advances in endostatin biology and highlights new results on the cellular and subcellular mechanisms of endostatin action.
-
Schmidt Annette, Wenzel Daniela, Ferring Isabell, Kazemi Shohreh, Sasaki Takako, Hescheler J�rgen, Timpl Rupert, Addicks Klaus, Fleischmann Bernd K., Bloch Wilhelm, Influence of endostatin on embryonic vasculo- and angiogenesis, Developmental Dynamics, 230, 3, 2004. Crossref
-
. N.A. Meguid, . E. Ashour, . A.A. Dardir, High Serum Endostatin Level in Egyptian Children with Down Syndrome: Gene Dosage Effect, Journal of Biological Sciences, 4, 3, 2004. Crossref
-
Pradilla Gustavo, Legnani Federico G., Petrangolini Giovanna, Francescato Pierangelo, Chillemi Francesco, Tyler Betty M., Gaini Sergio M., Brem Henry, Olivi Alessandro, DiMeco Francesco, Local Delivery of a Synthetic Endostatin Fragment for the Treatment of Experimental Gliomas, Neurosurgery, 57, 5, 2005. Crossref
-
Néstor T., Masckauchán H., Kitajewski Jan, Wnt pathways in angiogenesis, in Wnt Signaling in Embryonic Development, 17, 2007. Crossref
-
Field-Ridley Aida, Heljasvaara Ritva, Pihlajaniemi Taina, Adatia Ian, Sun Christine, Keller Roberta L., Gong Wen Hui, Datar Sanjeev, Oishi Peter, Fineman Jeffrey R., Endostatin, an Inhibitor of Angiogenesis, Decreases After Bidirectional Superior Cavopulmonary Anastamosis, Pediatric Cardiology, 34, 2, 2013. Crossref
-
Okada Muneyoshi, Oba Yoko, Yamawaki Hideyuki, Endostatin stimulates proliferation and migration of adult rat cardiac fibroblasts through PI3K/Akt pathway, European Journal of Pharmacology, 750, 2015. Crossref
-
Poluzzi Chiara, Iozzo Renato V., Schaefer Liliana, Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers, Advanced Drug Delivery Reviews, 97, 2016. Crossref
-
Abdollahi Amir, Hahnfeldt Philip, Maercker Christian, Gröne Hermann-Josef, Debus Juergen, Ansorge Wilhelm, Folkman Judah, Hlatky Lynn, Huber Peter E, Endostatin's Antiangiogenic Signaling Network, Molecular Cell, 13, 5, 2004. Crossref
-
Mohajeri Abbas, Sanaei Sarvin, Kiafar Farhad, Fattahi Amir, Khalili Majid, Zarghami Nosratollah, The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering, Advanced Pharmaceutical Bulletin, 7, 1, 2017. Crossref
-
Zhang Andrew Y., Teggatz Eric G., Zou Ai-Ping, Campbell William B., Li Pin-Lan, Endostatin uncouples NO and Ca2+response to bradykinin through enhanced O2−· production in the intact coronary endothelium, American Journal of Physiology-Heart and Circulatory Physiology, 288, 2, 2005. Crossref
-
Schaffhauser Birgit, Veikkola Tanja, Strittmatter Karin, Antoniadis Helena, Alitalo Kari, Christofori Gerhard, Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice, Journal of Leukocyte Biology, 80, 4, 2006. Crossref
-
Hasbum Asbiel, Quintanilla Jaqueline, Jr Juan A Amieva, Ding May-Hui, Levy Arkene, Chew Sue Anne, Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents, Future Medicinal Chemistry, 13, 4, 2021. Crossref
-
Ricard-Blum Sylvie, Féraud Olivier, Lortat-Jacob Hugues, Rencurosi Anna, Fukai Naomi, Dkhissi Fatima, Vittet Daniel, Imberty Anne, Olsen Bjorn R., van der Rest Michel, Characterization of Endostatin Binding to Heparin and Heparan Sulfate by Surface Plasmon Resonance and Molecular Modeling, Journal of Biological Chemistry, 279, 4, 2004. Crossref